Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 103.7M | 94.6M | 89.8M | 89.8M |
Selling general and admin | 40.3M | 29.6M | 32.3M | 31.4M |
Other operating expenses | — | — | — | — |
Operating income | -144M | -124.2M | -122.1M | -121.2M |
Non operating interest income | ||||
Income | 8.7M | — | 5.5M | 5.1M |
Expense | — | — | — | — |
Other income expense | 42M | -80.1M | 1.4M | 9.3M |
Pretax income | -93.3M | -198.3M | -115.2M | -106.8M |
Tax provision | 100K | -200K | 100K | 100K |
Net income | -93.4M | -198.1M | -115.3M | -106.9M |
Basic EPS | -0.2 | — | -0.3 | -0.3 |
Diluted EPS | -0.2 | — | -0.3 | -0.3 |
Basic average shares | 540.4M | — | 397.5M | 334.1M |
Diluted average shares | 540.4M | — | 397.5M | 334.1M |
EBITDA | -139.9M | -120.7M | -118.8M | -118.6M |
Net income from continuing op. | -93.4M | -198.1M | -115.3M | -106.9M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |